(C) Common Dreams
This story was originally published by Common Dreams and is unaltered.
. . . . . . . . . .



Bristol-Myers, Pfizer Sue to Block Copies of Blockbuster Eliquis [1]

[]

Date: 2023-08

Bristol-Myers Squibb Co. and business partner Pfizer Inc. allege that copies of Eliquis proposed by two makers of generic drugs infringe a patent for the blockbuster blood-thinner.

The pharmaceutical giants’ complaints—one against Biocon Pharma Ltd., another against ScieGen Pharmaceuticals Inc.—were filed April 6 and docketed Monday in the US District Court for the District of Delaware. They seek orders blocking the generics until after the Eliquis patent has expired, or cash compensation if copies of the drug are made before then.

Each copy infringes the companies’ US Patent No. 9,326,945, which will expire in February 2031, according ...

[END]
---
[1] Url: https://news.bloomberglaw.com/ip-law/bristol-myers-pfizer-sue-to-block-copies-of-blockbuster-eliquis

Published and (C) by Common Dreams
Content appears here under this condition or license: Creative Commons CC BY-NC-ND 3.0..

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/commondreams/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.